<!DOCTYPE html>
<html lang="en" dir="auto">

<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="noindex, nofollow">
<title>ECT – New and Improved? | Behaviorism and Mental Health</title>
<meta name="keywords" content="">
<meta name="description" content="I&rsquo;ve just come across a strange article on Mad in America.  It&rsquo;s called Researchers look at therapeutic benefits of ketamine.  You can see it here.  It doesn&rsquo;t identify an author, but it&rsquo;s from the University of Manchester.
The opening paragraph says:
&#34;The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe depression.&#34;">
<meta name="author" content="PhilHickeyPhD">
<link rel="canonical" href="http://localhost:1313/posts/ect-new-and-improved/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.2211ca3164be7830024f6aad2b3a2e520843a64f8f048445c3401c1249aa051d.css" integrity="sha256-IhHKMWS&#43;eDACT2qtKzouUghDpk&#43;PBIRFw0AcEkmqBR0=" rel="preload stylesheet" as="style">
<link rel="icon" href="http://localhost:1313/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="http://localhost:1313/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="http://localhost:1313/favicon-32x32.png">
<link rel="apple-touch-icon" href="http://localhost:1313/apple-touch-icon.png">
<link rel="mask-icon" href="http://localhost:1313/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" hreflang="en" href="http://localhost:1313/posts/ect-new-and-improved/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="http://localhost:1313/" accesskey="h" title="Behaviorism and Mental Health (Alt + H)">Behaviorism and Mental Health</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)" aria-label="Toggle theme">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="http://localhost:1313/categories/" title="Categories">
                    <span>Categories</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main">

<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title entry-hint-parent">
      ECT – New and Improved?
    </h1>
    <div class="post-meta"><span title='2013-05-10 13:15:40 +0000 UTC'>May 10, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD

</div>
  </header> 
  <div class="post-content"><p>I&rsquo;ve just come across a strange article on Mad in America.  It&rsquo;s called <i>Researchers look at therapeutic benefits of ketamine</i>.  You can see it <a href="http://www.manchester.ac.uk/aboutus/news/display/?id=9956">here</a>.  It doesn&rsquo;t identify an author, but it&rsquo;s from the University of Manchester.</p>
<p>The opening paragraph says:</p>
<p style="padding-left: 30px;">"The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe depression."</p>
The research team is to be led by Professor Ian Anderson, a psychiatrist, who is quoted as saying:
<p style="padding-left: 30px;">“It’s a great opportunity to really study ECT and see how we can improve it. ECT is the most effective treatment we have for severe and Treatment Resistant Depression – but it can cause cognitive and memory difficulties as a side-effect."</p>
It's to be a randomized controlled study.  They're planning to recruit 160 participants who have been referred for ECT, and then randomly assign them to ECT alone or ECT plus ketamine.
<p>COMMENT</p>
<p>I was struck firstly by the comment that this is to be the largest trial into the use of shock &ldquo;treatment&rdquo; in 30 years in the UK.  There are to be 160 people in this study, which doesn&rsquo;t seem all that large given the level of controversy surrounding this &ldquo;treatment.&rdquo;</p>
<p>Secondly I was struck by Dr. Anderson&rsquo;s statement that shock &ldquo;treatment&rdquo; can cause cognitive and memory <i>difficulties</i> as a <i>side effect</i>.  The term &ldquo;difficulties&rdquo; seems like an understatement.  There is ample documentation in the literature that the memory losses are often massive and devastating.  It is also the case that several authorities on shock &ldquo;treatment&rdquo; have stated very clearly that memory loss is <i>not</i> a side-effect, but rather is the <i>main</i> effect.  The rationale that has been presented is that the electric current alleviates depression by obliterating painful memories!</p>
<p>It has also been well documented, incidentally, that <strong>shock &ldquo;treatment&rdquo; is no more effective</strong> at alleviating depression <strong>than <i>sham</i> shock treatment</strong>, where the person is anesthetized but <i>not shocked.</i></p>
<p>KETAMINE</p>
<p>But what surprised me most was the proposed use of ketamine as an adjunct to shock &ldquo;treatment.&rdquo;</p>
<p>Ketamine is a drug used as an anesthetic for animals, and in certain circumstances for humans.  Its effects in humans include anesthesia and hallucinations.  It is used recreationally as a psychedelic drug (street name: Special K), and is in the same drug class as phencyclidine (PCP), also known as Angel Dust.</p>
<p>Dr. Anderson expresses the hope:</p>
<p style="padding-left: 30px;">"…that ketamine will reduce the longer-term loss of past memories, including autobiographical memory – which may include memories of childhood holidays, growing up and early life – that some people experience with ECT and which can be very distressing."</p>
CONCLUSION
<p>I&rsquo;m no neurologist, but it is my understanding that 450 volts of electricity coursing across the brain causes damage.  I find it hard to imagine how the concomitant injection of a hallucinatory anesthetic could have a mitigating effect on this damage.  I&rsquo;m left with the suspicion that perhaps the researchers are hoping that the <i>euphoric</i> effects of the drug will reduce post-procedural complaints of headaches and feeling &ldquo;wiped out.&rdquo;</p>
<p>In other words, the drug might have some effect on what clients <i>say</i> about the treatment (i.e. fewer complaints), but it <strong>seems unlikely that it will reduce the amount of brain damage or memory loss</strong>.</p>


  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="http://localhost:1313/">Behaviorism and Mental Health</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
